Clinical trials
Withdrawn Phase 1 Stomach Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2007 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2022 | 2 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 12 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Beijing Kejing Biotechnology Co., Ltd. | 1 |
| Conjupro Biotherapeutics, Inc. | 1 |
| GC Cell Corporation | 1 |
| Lynkcell Inc. | 1 |
| NYU Langone Health | 1 |
| National Cancer Institute (NCI) | 1 |
| Orion Biotechnology Polska Sp. z o.o. | 1 |
| Roger Williams Medical Center | 1 |
| Sorrento Therapeutics, Inc. | 1 |
| Themis Bioscience GmbH | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Stomach Neoplasms | 12 |
| Colorectal Neoplasms | 5 |
| Pancreatic Neoplasms | 5 |
| Breast Neoplasms | 4 |
| Esophageal Neoplasms | 4 |
| Ovarian Neoplasms | 4 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Lung Neoplasms | 2 |
| Neoplasm Metastasis | 2 |
| Adenocarcinoma | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.